Palvella Therapeutics, Inc. ( PVLA) - Stock Earnings
PVLA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -12.7 million USD | — USD |
| 2026Q1 | -15.8 million USD | — USD |
| 2026Q2 | -21.9 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
PVLA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 18.7 million USD | — USD |
| 2024 | -17.4 million USD | — USD |
| 2025 | -41.7 million USD | — USD |
| 2026 Est. | — | — |
PVLA
Price: $140.99
52 week price:
Earnings Per Share: -4.69 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.2 billion